June 4, 2012

ASCO 2012 Multiple Myeloma Update – Day Three: New Myeloma Treatments


One of the morning presentations was given by Dr. Melissa Alsina from the H. Lee Moffitt Cancer Center in Tampa, Florida.  Dr. Alsina presented a Phase 2 study of panobinostat in combination with Velcade (bortezomib) and dexamethasone (Decadron)… The panobinostat trial results were reviewed by Dr. Asher Chanan-Khan of the Mayo Clinic in Jacksonville, Florida, in a presentation that also took place during this morning’s session.


Myeloma Beacon

Tags: Cancer, Dr. Asher Chanan-Khan, Dr. Melissa Alsina, Facilities, H. Lee Moffitt Cancer Center, Mayo Clinic Jacksonville, multiple myeloma, Myeloma Beacon, Preventive Medicine, Research

Please sign in or register to post a reply.
Contact Us · Privacy Policy